•  
  •  
  •  
  •  

2023-01-29 21:19:38

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • HFCL Ltd and HTL Ltd receive orders worth Rs. 206.67 crores
  • Krsnaa Diagnostics operationalizes 1 Diagnostic Center in UP
  • Indiabulls Enterprises Ltd consolidated Q3FY23 profit at Rs. 1.51 crore
  • Capri Global Capital Ltd Q3 FY2023 consolidated net profit slides to Rs. 37.41 crores
  • CARE Ratings Ltd reports consolidated PAT of Rs. 15.95 crores in Q3FY23

Keywords Selected:  ExtendedReleaseTablets

Stock Report

  • Lupin receives approval from U.S. FDA for Fesoterodine Fumarate Extended-Release Tablets
  • JB Chemicals & Pharmaceuticals Ltd receives ANDA approval for Venlafaxine Hydrochloride Extended-Release Tablets from USFDA
  • Alembic Pharmaceuticals receives USFDA Final Approval for Nifedipine Extended-Release Tablets USP, 30 mg, 60 mg and 90 mg
  • Zydus receives final approval from USFDA and 180 days shared exclusivity for Mirabegron Extended-Release Tablets
  • Lupin receives approval from U.S. FDA for Mirabegron Extended-Release Tablets
  • Zydus receives two final approvals from the USFDA for Venlafaxine Extended-Release Tablets and Pregabalin Extended-Release Tablets
  • Lupin launches Desvenlafaxine Extended-Release Tablets in the United States
  • Unichem Laboratories receives ANDA Approval for Quetiapine Extended-Release Tablets
  • Dr. Reddy's Labs launches Fesoterodine Fumarate Extended-Release Tablets in the U.S. market
  • Lupin receives approval from U.S. FDA for Paliperidone Extended-Release Tablets
  • Unichem Laboratories ANDA approval for Divalproex Sodium Extended-Release Tablets

Latest Post

  • HFCL Ltd and HTL Ltd receive orders worth Rs. 206.67 crores
  • Krsnaa Diagnostics operationalizes 1 Diagnostic Center in UP
  • Indiabulls Enterprises Ltd consolidated Q3FY23 profit at Rs. 1.51 crore
  • Capri Global Capital Ltd Q3 FY2023 consolidated net profit slides to Rs. 37.41 crores
  • CARE Ratings Ltd reports consolidated PAT of Rs. 15.95 crores in Q3FY23


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
No:AP-172, 2nd Sector, 10th Street, KK Nagar
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-80560-88967
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

Disclaimer Copyright © - 2022